Literature DB >> 10587397

An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh.

F Verlato1, P Zucchetta, P Prandoni, G Camporese, M C Marzola, G Salmistraro, F Bui, R Martini, F Rosso, G M Andreozzi.   

Abstract

PURPOSE: The rate of objectively proven pulmonary embolism in patients with thrombophlebitis of the greater saphenous vein was studied.
METHODS: Consecutive ambulant patients with thrombophlebitis of the greater saphenous vein, involving the above-knee segment, underwent a complete venous echo color Doppler examination of the lower limbs, perfusion lung scanning, and chest radiography. A high probability of pulmonary embolism was defined as the presence of two or more large segmental defects, one large and two or more moderate perfusion defects, or four or more moderate perfusion defects, with no corresponding abnormality found by means of chest radiography.
RESULTS: Of the 21 patients included in the study, findings compatible with a high probability of pulmonary embolism were detected in seven patients (33.3%; 95% CI, 14.6 to 57. 0), although clinical symptoms of pulmonary embolism were present only in one patient. No association was found between the presence of thrombosis at the saphenofemoral junction and the risk for pulmonary embolism.
CONCLUSION: The rate of pulmonary embolism in patients with thrombophlebitis of the greater saphenous vein is unexpectedly high. This risk is similarly high in patients with thrombosis at the saphenofemoral junction and in patients without thrombosis at the saphenofemoral junction. Our results are consistent with those of other recent investigations and suggest that superficial thrombophlebitis of the thigh is not as benign a disease entity as previously described.

Entities:  

Mesh:

Year:  1999        PMID: 10587397     DOI: 10.1016/s0741-5214(99)70051-0

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  15 in total

1.  Superficial thrombophlebitis followed by pulmonary embolism.

Authors:  P Kesteven; B Robinson
Journal:  J R Soc Med       Date:  2001-04       Impact factor: 5.344

Review 2.  [Ultrasound diagnostic techniques in dermatologic angiology and phlebology].

Authors:  G Hesse; H Stiegler
Journal:  Hautarzt       Date:  2003-05-29       Impact factor: 0.751

Review 3.  [Superficial venous thrombosis. A review].

Authors:  C Jeanneret; S Brunner
Journal:  Hautarzt       Date:  2012-08       Impact factor: 0.751

4.  Postoperative Massive Pulmonary Embolism Due to Superficial Vein Thrombosis of the Upper Limb.

Authors:  Marco Cascella; Daniela Viscardi; Francesca Bifulco; Arturo Cuomo
Journal:  J Clin Med Res       Date:  2016-02-27

Review 5.  S2k guidelines: diagnosis and treatment of varicose veins.

Authors:  F Pannier; T Noppeney; J Alm; F X Breu; G Bruning; I Flessenkämper; H Gerlach; K Hartmann; B Kahle; H Kluess; E Mendoza; D Mühlberger; A Mumme; H Nüllen; K Rass; S Reich-Schupke; D Stenger; M Stücker; C G Schmedt; T Schwarz; J Tesmann; J Teßarek; S Werth; E Valesky
Journal:  Hautarzt       Date:  2022-04-19       Impact factor: 1.198

6.  Treatment of mobile right heart thrombi with low-molecular-weight heparin.

Authors:  Konstantinos M Lampropoulos; Maria Bonou; Constantinos Theocharis; John Barbetseas
Journal:  BMJ Case Rep       Date:  2013-03-25

7.  Clinical Features and Developing Risks of Saphenous Vein Thrombophlebitis.

Authors:  Hiroto Rikimaru
Journal:  Ann Vasc Dis       Date:  2016-05-04

Review 8.  Superficial venous thrombosis: disease progression and evolving treatment approaches.

Authors:  Maria E Litzendorf; Bhagwan Satiani
Journal:  Vasc Health Risk Manag       Date:  2011-08-31

Review 9.  Treatment for superficial thrombophlebitis of the leg.

Authors:  Marcello Di Nisio; Iris M Wichers; Saskia Middeldorp
Journal:  Cochrane Database Syst Rev       Date:  2018-02-25

10.  Endovenous saphenous vein ablation in patients with acute isolated superficial-vein thrombosis.

Authors:  Wayne S Gradman
Journal:  Phlebology       Date:  2013-12-04       Impact factor: 1.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.